Dana Blankenhorn

Dana Blankenhorn

Expertise: Technology, Biotech, Renewable energy

Education: M.S,J. Northwestern (Medill School) 1978; B.A. Rice University, History and Political Science 1977

Awards & Accomplishments: Tech reporter since 1982, Freelance since 1983, on Internet since 1985. Created first online coverage of Internet with a magazine, Interactive Age, 1994 Co-wrote BBS Systems for Business in 1991, Wrote Guide to Field Computing in 1992 Wrote technology history now called "Living with Moore's Law" in 2001, 2010, 2021 Author of over a dozen books, both fiction and non-fiction

About Dana:
Dana Blankenhorn has been a financial journalist since 1978, a technology journalist since 1982, and an Internet journalist since 1985. He writes a Substack newsletter, Facing the Future, which covers technology, markets, and politics.

He has written a half-dozen technology books, several novels available at the Amazon Kindle store, and covered beats ranging from education to e-commerce, and from open source to renewable energy. He lives in Atlanta.

Recent Articles

ViacomCBS Stock’s Best Hope Is Buyout After Archegos Knock-Down

ViacomCBS stock was riding high until the unwinding of Archegos Capital cut its price in half. It is still a viable business, but it won't be in five years unless it's sold.

Apple Stock Still Has Catalysts To Retain ‘Most Valuable’ Title

Apple can still grow through health apps, financial apps and in streaming, along with its own silicon entry. Still want to sell your AAPL stock?

Adobe Systems Is a Safe Cloud Play

Adobe Systems may find growth harder to come by, with competition from other cloud players, but ADBE stock is still a safe play.

Social Hedosophia Line-up Is Brainchild of the Great Gatsby of SPACs

Like The Great Gatsby, Social Hedosophia's Chamath Palihapitiya is a man of his time. Like The Music Man, he's an inveterate promoter, in this case of SPACs.

Apex Technology Acquisition Looks Good Especially as SPAC Exhaustion Sets In

AvaPoint has a great niche as a back-up solution for Microsoft 365, experienced managers and reasonable growth projections through 2022.

Zomedica’s Knowns, Known Unknowns, and its Unknown Unknowns

Truforma uses acoustic radio waves to analyze the chemical composition of small samples, and can diagnose some common diseases of dogs and cats.

SRNGU Stock: Betting the Sponsors Is True SPAC Speculation

Eagle Acquisition is looking for its seventh deal with SRNGU stock. The team behind it previously took DraftKings and Skillz public.

7 Ways to Define a Blue-Chip

The ranks of blue-chip stocks are constantly changing, and what you call a blue-chip investment will also change as you age.

VG Acquisition Stock: The Value’s in the DNA Vault, Not the Spit Kits

If 23andme is worth $3.5 billion, it's based on the long-term asset of its DNA database, not the cash it gets from consumers for its saliva testing kits.

BowX: Run, Don’t Walk, From the WeWork IPO

WeWork lost $3.2 billion last year and now calls itself a technology platform for creating flexible workspaces.